Monday, May 27, 2019


By: Dr. Robert Bard (Cancer Imaging Historian)
Edited by: Prof. Rodolfo Campani

The record of cancer treatment advancements carry a significant debt to a community of Italian clinical pioneers- recognized for their extensive contribution to the screening, imaging and diagnostic innovations. Names such as Drs. Luigi Solbiati, Carlo Martinoli and Rodolfo Campani are some of the top names that helped to pave the movement for a much improved detection of cancer tumors and other subdermal disorders.

Since the German discovery of the X-Ray in 1890, scientists worldwide found the drive to mobilize diagnostic science into a non-invasive direction. Scanning technology carried the potential to save lives by enabling images of physiological issues underneath the skin non-invasively- or without any cutting. But it wasn't until 1977 that the results of radiologicical imaging advanced to the capacity of cancer detection as the Magnetic Resonance Imaging (MRI) was developed by Armenian-born Dr. Raymond Damadian who performed the first full body scan to diagnose cancer and refining the focus of modern radiology.

The Bracco Imaging Group (headquartered in Milan, Italy) established the first multinational healthcare group in 1927, and heavily supported many contributions to clinical diagnostic science including the launch of the advancement of CONTRAST agents for all imaging solutions. It is this material injected in the bloodstream that allowed a significant improvement in identifying tumor cells.

Leonardo Da Vinci detailed over 500 years ago about the way the blood flowed in and out of the heart and showed how the valves worked. It wasn't until 1960 that the medical community caught up to Da Vinci and confirmed all this time that he was remarkably correct! A jump to the 1990's became a pivotal period as European imaging has standardized the non-invasive ultrasound technology to be a major screening protocol for cancer investigation.

One of the leading pioneers in this study was Professor Rodolfo Campani who started the first world study of ultrasound contrast agents in humans in Italy in 1990. The Scientific Journal of the Italian Society of Radiology "La Radiologia Medica" (reported in May 1993) presented the results of the 5 Italian experimentation centers under his coordination at the Institute of Radiology in the University of Pavia. He was credited for developing the first (non-radiation based) ultrasound contrast agent which are used to show BLOOD FLOW in tumors, elevating the power of the ultrasound to out-perform MRI's, X-rays and CT Scans. Implementation of this contrast was a generational leap in advantages because it made the tumor vascularity much more easily visible using the injectable and safe ultrasound contrast agent. Unlike the MRI contrasts (which contained heavy metals) the ultrasound contrast was comprised of air bubbles and microalbumin. In a 1994 journal, this contrast was first used in liver cancers where vascularity is highlighted inside the liver.

With this same time span, CARLO MARTINOLI, MD (Genoa) arose as another contributor to the widespread use of ultrasound technology by emphasizing the effects of ultrasound imaging of the musculoskeletal and peripheral nervous systems. He helped shape modern medical education to recognize and include the studies of ultrasound and musculoskeletal radiology and coauthored vital textbooks on the subject which are still in use today in over 22 countries.

PROFESSOR LUIGI SOLBIATI (Milan) specialized in the study of blood flow of cancers and published his discoveries about the major differences between malignant and benign tumor vessels. This study helped to shape the way non-invasive imaging protocols like the newer Doppler sonography & MRI diagnostic techniques identify cancers. He pioneered ultrasound-guided aspiration biopsies (1979), ethanol injection (1983), radiofrequency ablation with cool-tip electrodes (1995) and microwaves (2009) of solid tumors and fusion imaging for the guidance of interventional procedures (2003)

Modern studies confirm that metastasis (the spread of cancer to other areas of the body) and cell migration is mobilized by blood flow, and it is here that diagnostic protocols examine other clues as to the condition of the existing tumors. Digital ultrasound imaging with blood flow technology, the doppler blood flow, and the contrast enhanced blood flow was pioneered and developed by Rodolfo Campani and Luigi Solbiati (from Busto Arsizio/Varese) where they introduced worldwide the performance of the Doppler Ultrasound as a viable and more accurate technology for diagnosing tumors and assessing tumor response in many different areas.

(End of part 1)
About the Author:
Robert L. Bard, MD, PC, DABR, FASLMS is internationally known and recognized as a leader in the field of 21st Century 3-D ULTRASONOGRAPHIC VOLUMETRIC DOPPLER IMAGING. Dr. Bard specializes in advanced 3-D sonography to detect cancers in numerous organs including the breast, prostate, skin, thyroid, melanoma and other areas. Dr. Bard’s images are used to accurately guide biopsies, target therapy and provide focused follow-up after treatment. As of Jan '18, Dr. Robert Bard spearheaded a partnership with a host of cancer educators, medical practitioners and non-profit foundations (allied under to form a public resource program to aid in the advancement of the public's understanding about self-preservation from cancer and other chronic diseases. EARLY DETECTION & PREVENTION is a global health movement that promotes a higher regard for "clean living" - from toxins and a toxic lifestyle. Our program consists of four main efforts: EDUCATION, COMMUNITY CONNECTION, CURRENT NEWS & CLINICAL RESOURCES. EARLY DETECTION & PREVENTION brings the empowerment of wellness through group seminars, videos and the distribution of current articles & newsletters published/shared to all the major cancer charities and their members. For more information or to subscribe to our EARLY CANCER DETECTION & PREVENTION PROGRAM newsletter, contact Bard Cancer Diagnostics today at: 212.355.7017 ( or email us at:


Special thanks to the Columbia Association (FDNY) for their interest in exploring the history of cancer treatment and Italian solutionists.  5/14/2019 New Hyde Park, NY -- Chapter VP John Signorile introduces NYCRA's cancer advocates to present topics of awareness and available resources for checkups. In support of the Italian Heritage that the Columbia Association supports throughout its history, Dr. Bard produced this article as a gift to the organization and community it represents - uncovering the highly notable Italian contributors to cancer research. This archive study continues to expand in future volumes and issues.

Saturday, May 25, 2019


Our modern medical science owes a great debt to the veterinary community and the animal kingdom for the early treatment discoveries and advancements of STEM CELL research.  The science of regenerative medicine started in 1981 from early mouse embryos, which led to the development of growing cells in laboratories.  Today, the use of stem cells in humans is still considered experimental, while veterinary medicine has outnumbered human cases with the vast number of animals treated successfully. [1]

We reached out to Veterinarian and leading Stem Cell expert, Dr. Michael Hutchinson (PA) who has performed more than 1500 Adipose-Derived Stem Cell procedures on dogs, cats, horses, camels and a bird, among his 20,000 surgeries in 33 years of practicing veterinary medicine. His insights on this healing marvel for animals have proven its value in the preservation of life and wellness recovery- such that its growing popularity in the treatment of pets can reflect many similarities and future successes in humans to foster acceptance and confidence as a proven treatment option.

Interview with Dr. Michael Hutchinson
In 2005, I had a Saturday morning radio program in Pittsburgh where I focused on topics that interested me.  I was intrigued by a laboratory from CA who showed some success with stem cells in horses first, and then dogs & cats.  They were introducing this science only to specialists in the veterinary field, but it was my persistence in letter writing that encouraged them to offer this to general practitioners (including myself).

By 2008, I treated my first dog, and soon after, I started getting invited to treat horses (something I was quite familiar with out in Long Island from '86 to '98). I had experience with farm animals in my background, so I was interested in stem cells for all the issues that we saw in animals. It didn't matter if it was a bird or a horse - I was interested in getting these repair cells out and helping these animals with maladies that were not being treated very well with the standard of care.   This failure of the standard of care led me down the road of clinical research where we started doing studies on kidney disease, degenerative myelopathy (similar to Lou Gehrig's disease or ALS), liver disease, arthritis and autoimmune diseases where the immune system would attack the body.

Over time, we expanded to the use of blood stem cells. A doctor and researcher from Melbourne, AU- Dr. Vasilis Paspaliaris, developed a system to harvest significantly higher-level microscopic stem cells out of the blood. He offered me to compassionately try it in animals for different conditions, especially those related to liver disease, kidney disease, and some degenerative nerve issues.  This new blood protocol expanded my compassionate use in clinical trials for diseases that did not adequately respond to the fat-derived stem cells. 

By 2010, my research has led me to align with MediVet Biologics for their impressive work with adipose-derived cells.  Their research and continued advancements earned my trust to help pave the way in this study.  MediVet’s procedure kit was considered a major scientific breakthrough for many disorders like osteoarthritis, hip dysplasia, ligament and cartilage injuries.

Patients journey from all over to experience the results of stem cell treatments for their pets. They suffer a wide range of issues from neurological deficits, autoimmune disorders to musculoskeletal damage. People who have had no success with other therapies are even willing to travel from different places in the US to have this available to them. Then we follow these treated animals to see if we're going to be able to help more animals or share protocols with the human side - which is my ultimate goal.

Importantly, stem cell therapy is not a panacea and is not meant for every condition out there. I don't think we veterinarians and doctors should be treating everything; I think we should be very mindful that we have reasonable expectations before recommending stem cell treatments. There is a finite list of disorders with pets that I am relatively confident in treating. One of them is Osteoarthritis (OA).  It's the predominant condition that I manage utilizing fat-derived stem cells with dogs and evaluating symptoms for this is relatively cut and dry. If your dog is having trouble going up and down the steps, getting in and out of the car, going to the bathroom in one place, exhibiting pain and discomfort in joints or having trouble getting up from a laying down position, those are the telltale signs for OA.

Upon examination, if the animal is experiencing these symptoms and is showing no other issues, then I have a reasonable expectation (90%) that your dog's going to respond very well. Of course, not every osteoarthritis case will end the same, but we can predict with a very high expectation that we're going to have success.  I base this on over 1,500 treatments, and the majority of them are Osteoarthritis.

When I treat this type of case, I inject the joints with stem cells after extracting and processing the fat (surgery to collect fat takes about 15 minutes and the processing an additional 2 - 3 hours). I would primarily choose fat stem cells, or MSCs (mesenchymal stem cells) to treat OA.  They're the number one cell that's researched and published around the globe.  You get them out of bone marrow, fat or several tissue types, but it's fat that shows the highest harvest numbers.

If I'm treating Osteoarthritis, these MSC's come out of the same germ layer (Mesoderm) as the cartilage, as the tendons, as the ligament- as the bone…and because it comes out of the same germ layer, it's a more logical repair cell to use, especially if you're hoping to achieve some regeneration of cartilage along the affected joints.  We can also administer the cells through the use of a Hema-filter and an intravenous catheter… we're talking about (their own) autologous cells, so there is no risk of rejection. Since these stem cells are similar in size to the red blood cells, they can easily cross the blood-brain barrier and potentially help with the pain centers as well. We may not always get cell regeneration, but we almost always get a profound anti-inflammatory and immune-modulatory effect that lasts around a year and a half on average. Now, if I have a severely arthritic dog, maybe it was an athlete and had several injuries throughout its life, that dog may require more than one treatment that may not last as long as a year and a half. It may last six to eight months. However, I call it my "Gold Therapy" because it's profoundly better than the standard of care in many cases. 

(End of part 1)

2) Dr. Mike Hutchinson (website)-
3) MediVet Biologics (website)


About "Dr. Mike" Hutchinson-
A leading practitioner in stem cell therapy, Dr. Mike Hutchinson, DVM, is a highly sought after speaker at national and international veterinary conferences on the uses of animal stem cells.  He also has co-authored "Discussion of Animal Stem Cells in the Classroom: Engaging Students through the Lens of Veterinary Medicine", published in The American Biology Teacher, and co-authored a study on Serotypes of Bovine Astrovirus, published in the Journal of Clinical Microbiology. He is the owner of Animal General of Cranberry and Chairman of the Board of VivaTech International, Dr. Mike is married and the father of five children. For additional interviews, you may contact Dr. Mike Hutchinson at 724-776-7930

Monday, May 6, 2019

Essentials of Cancer Prevention & Early Detection- by: Dr. Jesse Stoff

This presentation was written and delivered by Dr. Jesse A. Stoff, Immunology Specialist at the 2019 Male Breast Cancer Coalition Conference. It covers the major fundamentals that you can do to reduce your risk of getting cancer or a recurrence of cancer.

Nowadays, most cancers are initiated or triggered, by a toxin. Toxins, in high enough levels of concentration and the right type, can lead to cancer spikes in various populations. In the place where I live on Long Island, New York, it is known as a cancer cluster. We have the highest instances of breast and prostate cancer and the highest instances of thyroid disease in the United States.  Other places that are notable for cancer spikes are the infamous Love Canal. It brings back many memories for people. Nonetheless on Long Island, we have to deal with the toxins that were dumped there from Grumman and Fairchild Hiller and other members of the aerospace industry primarily during World War II.

Toxins are the number one cause of cancer initiation. It's toxins that get people into trouble in terms of cancer.  The kind of toxins that we are worried about are the petrochemicals, volatile organic hydrocarbons and heavy metals are on the top of the list.

What these toxins do is they can interact in several places in the sequence to initiate the activity of this particular enzyme called COX-2. This is a major enzyme that leads to an inflammatory response in the body. There are many toxins that can directly trigger the activity of COX-2 in the production of this Prostaglandin or PGE2 which ultimately leads to activation of the ERa receptor. There are two major receptors that are involved in transmission and information of estrogen, ERa and ERb. ERa is one that ultimately through activation of this enzyme and the CYP1B. These two add to the production of four hydroxy netradyle and the initiation of breast cancer.

Now, the initiation of a cancer does not mean that the person is actually going through to develop that disease, and that's very important, because initiation is just one step in the whole process. Once the cancer has been initiated, they only have issues of promotion and progression before they actually have a major problem. When we're looking at issues of promotion and progression, we're not talking about the toxins anymore. What we're talking about is the internal biochemistry of the individual. That's when it has an impact on the ability of the body to stop the cancer, to reverse the early cancers and to prevent the progression. All of us produce a certain number of cancer cells every day.

Many of you who have had cancer know about blood tests for tumor markers. And if you've ever looked at the normal range of a tumor marker, you'll see that the normal range is not 0 to 0. It's 0 to some number. And the reason is because all of us produce a certain number of cancer cells. Through the activity of our immune system, it destroys those cells. It identifies and destroys them and releases these proteins into the blood that we can measure as tumor markers, and we all run low levels of these things.
It's only when the immune system can't identify the abnormal cells anymore that they're allowed to progress into a cancer. The risk of getting cancer or the risk of getting a recurrence of cancer is inversely related to the health, strength and structure of your immune system. So, that's something to keep in mind because we're trying to prevent future problems.

As mentioned earlier, toxins are the number one way that cancers get initiated, and one of the things you might think about doing are some basic detox things on a regular basis.  A simple Google search will get you started on this path to better health. As one example of many, you’ll find that plastic bottles are not the best form of bottle water. Glass is better because if plastic bottles get hot, they can breakdown a little bit and create some issues, but it's better than what comes out of the tap around here.

A recent article that came out December of 2018 in JAMA (the Journal of the American Medical Association) that looked at organic foods in terms of cancer prevention. They concluded that eating an organic diet decreased the risk and risk of recurrence of all known cancers. An organic diet means you’re basically avoiding the toxins that could be cancer initiators, but you're also eating a diet that has a much higher nutrient density that your body needs in order to function and work properly.

For cancer to progress, it has to be a certain amount of genetic instability. Some common supplements include:
  • Vitamin D3
  • Indole-3-Carbinol
  • Curcumin
  • Supforaphane
  • Fish Oil
  • Green Tea
  • IV’s

There are others- and they act as genetic stabilizers. These things can help to limit, stop and reverse the progression of cancers in the different stages of this plasia, metaplasia, neoplasia, etc.

So, the progression of cancer isn't based upon the initiation, it's based upon the internal value chemistry of the person who's fighting it off. And these are some of the things that can stabilize those genetics.

Now, blood tests can give us a rough idea of where we are because the blood test will tell us about our internal biochemistry. There are four biochemical pathways that allow a cancer to progress, and those four pathways are oxidation, glycation, methylation and inflammation. So, here we have:
  • glycation
  • oxidation
  • methylation
  • and inflammation
-as the four major pathways that allow for cancer cells to progress into a disease. There are more sophisticated tests available as well.  But, nonetheless, this will look at those four internal pathways that allow for that progression.

Now, as mentioned earlier, the risk of getting cancer or recurrence is based upon the structure and function of the immune system. These are some very simple basic tests that one can order, any doctor can order these to see where you stand in that whole risk of cancer issues.

Some essential things that you should start doing today to modify your risk of getting cancer or a recurrence of cancer.

Water Testing & Filtration: First, go to and find out what's in your water. This is a free website with a national database then find out what the appropriate filter is that you need to get in order to filter that stuff out. There are many filters on the market and there are several that I like but nonetheless, the filter that you use should be tied to the toxins that you're exposed to.

Organic diet: This is critical. See (link)

Toxic Non-Metal Chemical test & Chelation: We want to start finding out what's already in your system so we can do something about it. GPL-TOX PROFILE (Toxic Non-Metal Chemicals text) is one of many tests that are available that looks at nonmetal chemicals.   Nonmetal chemicals that are toxins or are carcinogenic are basically the volatile organic hydrocarbons and this will test for 172 of them. If you find these things in your system, there are different medical things that can be done to chelate these things out and pull them out of your system before they have a chance to initiate a cancer.

Urine Test: When we're looking at heavy metals, visit This is a urine test, very simple test that your doctor can order to see what heavy metals in your system are there that can, again, be carcinogenic and initiators of cancer. If you find that these things are in your system, you want to pull them out before you have a lump. 

Comprehensive Toxicology Test: Next, if you've been exposed to some chemicals or toxins that aren't on the previous list, this is a national reference laboratory for toxicology, the number one in the country. ( They test for over 2500 different things, but at that point, it's a very specific test that you're ordering. So, if you know that you've been exposed to a certain chemical or toxin, you want to see to what extent it may be in your system, this test will tell you the answer.

Toxicity Result/Data Research: Now, if you've been exposed to a certain chemical or toxin as we all have and you find it's in your system and you're concerned about what it might do to you, this is a website ( run by our government. In the search bar, put in immune system and whatever that chemical is and find out what it does to your immune system because the immune system again is the part of our biochemistry that keeps us out of trouble relative to cancer. And you can also put in as a search term the name of that chemical and the word cancer. But you have to put in the work and in order for it to do an accurate search for you.

Confirmation Screening tests: If you're concerned from a screening point of view as to whether or not you already have cancer cells in your body, IVYGENE is an advanced blood test that performs like a liquid biopsy, and it looks for a specific change in genetics that indicate the activity of cancer cells. ( FDA cleared the test for breast cancer, lung cancer, colon cancer and liver cancer. If it comes back elevated, please get yourself screened and find out where it is. This is all part of early detection. They expect by the end of this year they'll be FDA cleared for over a dozen different cancers. There are other companies that are working on developing even more sophisticated versions of liquid biopsies, but at this point, this is the only game in town.

Start with Detox, Water and Organic diet. Target improved nutrition and acquire supplements that can stabilize the genetics if it seems you are at higher risk. Lab tests to check your biochemistry and immune system for a shift in structure & function. Lab test for different toxins. Liquid biopsy- (IvyGene) which happens to be the only one on the market that looks for the activity of cancer cells before they have formed a tumor.  

Lifestyle of course, plays a risk in terms of developing cancer, toxin exposure, stress and increase in levels of inflammation in the body. So, engage in activities that modify your level of stress. The two easiest ways of dealing with stress is sleep- particularly the sleep before midnight. The other way to easily deal with stress is by doing things for fun. Now, in medicine, we have a definition for everything. Fun is defined as doing something for the experience and not the outcome.

If the liquid biopsy comes back positive, we have screening exams, ultrasounds, mammograms, MRIs,  physical exams. And the point of all of this that I'm sharing with you today is to reduce your risk now and in the future about getting any sort of cancer or recurrent if you've already had it so that you can live long and prosper.

Friday, May 3, 2019

"Armchair Seminars": The New Trend in Public Education

April 19, 2019, Dix Hills, NY-  Stem Cell Specialist Dr. Andrew J. Rochman test-drove a new and growing trend in private seminars and clinical public speaking.  Where doctors have often presented on stage at medical conferences, trade shows and wellness expos, a new face in info-sharing delivery is fast becoming the preferred environment for public speaking for private health education.

We've talked about doing a public speaking event for quite some time", says Dr. Rochman. "Finding the right location and setting defines the very personality of the message and until now, we couldn't come up with that proper venue that made sense for this topic. When you think about Stem Cell being a very modern yet exploratory science targeting such a wide range of patient types, ages, lifestyles and cultures... I couldn't see this happening in a classroom or a corporate theater. Knowing this audience, that type of setting would evoke so much stuffiness and tension to the message whereas bringing this into a home setting level (like what we did) allowed us to go from academic & clinical dialogue into a sharing circle- capturing the same nuance of visiting your uncle's house."

With less-than a and would ask about this highly curious pain treatment modality that continues to evolve, advance and capture new ground.  Sufferers of othopedic injuries, COPD, auto-immune disorders & arthritis are usually the popular caller.  But over time, other unique cases such as Parkinson's, Diabetes, Stroke and MS are now catching up to medical reports of success in being managed with cell regenerative therapies.
two week lead time, Dr. Rochman's office contacted as far back as four months worth of phone inquirers.  Men and women of all ages often connect from his website (

Thanks to the recent revolution in information (web) access, exploring new modalities for pain relief has become so much easier.  Medical speaking events and private seminars like this one certainly help the overall decision-making process, but the average attendee came with a certain amount of collective knowledge about the topic before walking in the door as reflected by the questions they asked. Event promoter Robyn Stimmel donated her lovely suburban abode (Dix Hills, NY) to this educational experiment. "Personally, attending a seminar of this intensity should be in an atmosphere that's comfortable in its surroundings.  I volunteered my home to have Dr. Rochman deliver this  Regenative Medicine seminar because it felt like a good match with his warm and engaging presence.  We got great positive feedback about the intimacy from the cozy environment we created!"

Dr. Rochman's event team explored a bevy of options for the launch of this speakere series. Understanding this type of audience plays a major role in the design of this educational program -including the use of Ms. Stimmel's home.  "The very topic of stem cell tends to attract fairly educated individuals who are active in researching for better answers", states Dr. Rochman. "This is a grown-up crowd who have significant health concerns. With those concerns also come a certain level of disappointment and distrust in prior treatment solutions... and the last thing they need is to be 'talked down to' with more pedantic medical jargon.  The same way I talk to any of my patients, this audience deserves real education and down-to-earth facts that anyone can understand."


Dr. Andrew J. Rochman is a NY Board-Certified Surgeon and a leader in advanced surgical techniques. He is a graduate of Colgate University and received his formal medical training from Nordestana University in 1981. He is an active member of the American Medical Association, the Medical Society of the State of New York, Nassau County Medical Society and the American College of Phlebology. Dr. Rochman currently manages several practices in the specialized sciences of advanced vein therapy, gallbladder surgery and stem cell therapy.  For more information on his current practice, visit: 

All articles posted in this blogsite include their own content reference links identifying where information of each article are sourced. We do not claim that these treatments work for any listed nor unlisted condition, intended or implied.  Dr. Andrew J. Rochman, "Cellular Therapies of NY",its employees and agents, assert no claims regarding the efficacy or appropriateness of any form of treatment mentioned In our blog site and other programs whereby we not promoting cell regenerative (stem cell) therapy as a cure for any condition, disease, or injury. No statements on this blog site have been evaluated or approved by the FDA. This blog site contains no medical advice whereas all statements and opinions provided are for the sole intent of educational, informational or editorial purposes only and we (the writers & publishers) do not make claims to diagnose or treat via this blogsite or other communication means. Cellular Therapies of NY, Dr. Andrew J. Rochman  does not claim that any applications or potential applications using stem cells are approved by the FDA, or are even effective. It’s important for potential patients to do their own research based on the options that we present so that one can make an informed decision. If you have ANY concerns with Cellular Therapies of NY, Dr. Andrew J. Rochman’s methods, this blog site, or technique, please contact us at 516-280-1333 so that we can investigate the matter or concern immediately.